Trevi Therapeutics Hires Dr. Helena Brett-Smith as Chief Development Officer

World News: . []

Trevi Therapeutics Inc Trevi or the Company a late-stage clinical development company focused on developing Nalbuphine ER for chronic pruritus itch today announced that it has hired Helena Bret t-Smith...

More news and information about Trevi Therapeutics, Inc.

Published By:

Business Wire: 13:38 GMT Thursday 12th October 2017

Published: .

Search for other references to "trevi" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers